Stuart Duty
Director at Foghorn Therapeutics Inc. (FHTX) since May 2025
Stuart Duty has filed 18 insider reports with the SEC since March 2023, as director at Foghorn Therapeutics Inc. (FHTX), director at Milestone Pharmaceuticals Inc. (MIST) and director at EyePoint, Inc. (EYPT) and at 1 more company. The latest filing, on June 25, 2026, reports grant or award at Foghorn Therapeutics Inc. (FHTX).
- Filings
- 18
- Companies
- 4
- Bought on market
- None
- Sold on market
- None
Companies where Stuart Duty is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Directorsince May 2025 | $1.78 | Jun 25, 2026 | |||||
| Directorsince July 2024 | $0.3993 | Jun 12, 2026 | |||||
| Directorsince October 2023 | $0.2642 | Jan 6, 2026 | |||||
| Directorsince March 2023 | $6.78 | Jun 10, 2025 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jun 24, 2026FHTXSEC Form 4 filed by Director Duty StuartForm 4Grant or award
- Jun 10, 2026MISTSEC Form 4 filed by Director Duty StuartForm 4Grant or award
- Jan 2, 2026EYPTSEC Form 4 filed by Director Duty StuartForm 4Grant or award
- Jun 10, 2025MISTSEC Form 4 filed by Director Duty StuartForm 4Grant or award
- Jun 6, 2025ACHVSEC Form 4 filed by Director Duty StuartForm 4Grant or award
- May 1, 2025FHTXSEC Form 4 filed by Director Duty StuartForm 4Grant or award
- May 1, 2025FHTXStuart Duty became an insiderForm 3New insider
- Jan 3, 2025EYPTSEC Form 4 filed by Director Duty StuartForm 4Grant or award
- Aug 28, 2024MISTSEC Form 4 filed by Director Duty StuartForm 4Grant or award
- Jul 15, 2024MISTSEC Form 4 filed by Director Duty StuartForm 4Grant or award
- Jul 15, 2024MISTStuart Duty became an insiderForm 3New insider
- Jan 22, 2024ACHVSEC Form 4 filed by Duty StuartForm 4Grant or award
- Jan 5, 2024EYPTSEC Form 4 filed by Duty StuartForm 4Grant or award
- Oct 16, 2023EYPTSEC Form 4 filed by Duty StuartForm 4Grant or award
- Oct 16, 2023EYPTStuart Duty became an insiderForm 3New insider
- Mar 29, 2023ACHVSEC Form 4 filed by Duty StuartForm 4Grant or award
- Mar 29, 2023ACHVSEC Form 4 filed by Duty StuartForm 4Grant or award
- Mar 29, 2023ACHVSEC Form 3: New insider Duty Stuart claimed no ownership of stock in the companyForm 3New insider
Compare Stuart Duty with
- Stuart Duty vs George Elston1 shared
- Stuart Duty vs Richard Alistair Stewart1 shared
- Stuart Duty vs Karen L. Zaderej1 shared
- Stuart Duty vs Thomas Sellig1 shared
- Stuart Duty vs Christopher Nathan Martin1 shared
- Stuart Duty vs Aaron Royston1 shared
Other insiders at the same companies
- Anthony J KrickMIST
- George ElstonEYPT
- Richard Alistair StewartACHV
- Karen L. ZaderejEYPT
- Thomas SelligACHV
- Christopher Nathan MartinACHV
- Aaron RoystonACHV
- Reid Alexander WaldmanACHV
- Jeffrey S FarrowACHV
- Nancy R. PhelanACHV
- Jay S. DukerEYPT
- Ramiro RibeiroEYPT
- Thomas J. Lynch Jr.FHTX
- Scott BillerFHTX
- Neil GallagherFHTX
- Michael MendelsohnFHTX
Questions about Stuart Duty
- What is Stuart Duty's role at Foghorn Therapeutics Inc.?
- Stuart Duty reports to the SEC as director at Foghorn Therapeutics Inc. (FHTX), according to the latest filing on June 25, 2026. Stuart Duty has also filed as director at Milestone Pharmaceuticals Inc. (MIST), director at EyePoint, Inc. (EYPT) and director at Achieve Life Sciences, Inc. (ACHV).
- Has Stuart Duty bought or sold stock recently?
- No open-market purchases or sales by Stuart Duty are on file. The filings report grant or award.
- How do I get alerts when Stuart Duty files?
- Follow Stuart Duty on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Stuart Duty (SEC CIK 0001970274). Totals count each trade once, skipping amendments whose original is on file, from Mar 30, 2023 on. View on SEC EDGAR · Get this as JSON